Business
Virginia cannabis firms expand medical facilities amid uncertainty over adult-use sales
Cannabis multistate operators in Virginia are focused on building out their medical marijuana facilities while they wait to see whether the commonwealth’s adult-use program actually launches in 2024 as planned, now that Republicans control much of the state government.
Virginia lawmakers last year approved legislation legalizing what would be the first commercial recreational marijuana market in the South. Democrats were then in control of state government.
But a 2024 launch is far from certain, sources told MJBizDaily, after Republicans retook the state House of Delegates and the governor’s mansion last November, throwing the upcoming recreational market – and its structure – into doubt.
In the meantime, representatives from Florida-based Jushi Holdings and New York-headquartered Columbia Care – which have MMJ licenses in Virginia – say they’re focused on opening their six total dispensaries allowed under state law.
They also are building out related infrastructure such as grow rooms and manufacturing facilities.
“We are feverishly working on building out our full complements of grow rooms,” said Trent Woloveck, chief commercial director at Jushi, who added that the company recently opened its third store in July, in Alexandria.
Jushi also has dispensaries operating in Manassas and Sterling, and all three are in the Washington DC metro area.
“We’ll have our Fairfax store open before the end of the month,” Woloveck added. “We just started construction of our fifth store in Arlington, and we’re finalizing our sixth site in Woodbridge and building out that facility there.”
The reason for that focus is threefold:
- The Virginia Legislature made major changes to the state medical marijuana program this year, including streamlining patient applications so consumers can buy products the same day they receive a doctor’s recommendation. That is expected to increase demand.
- The medical program continues to ramp up, and there’s plenty of infrastructure to build before a recreational cannabis market begins.
- The Legislature failed this year to reenact two bills needed to launch the adult-use marijuana market in January 2024. That means companies such as Jushi can count only on MMJ sales for the foreseeable future.
The changes for patient access are particularly notable.
Previously, patients had to wait up to six months to receive the necessary paperwork from the state Board of Pharmacy after obtaining a physician’s medical cannabis recommendation.
That requirement has been eliminated, which puts medical marijuana more on par with traditional prescriptions.
“With the expanded access for patients … we’re really focused on getting all of our satellite locations up and running so we can service as many as possible,” said Ngiste Abebe, vice president of public policy at Columbia Care.
Columbia Care is set to be acquired by Illinois-based Cresco Labs, but that deal hasn’t closed yet, and Cresco Labs directed questions about Virginia to Columbia Care.
So far, Columbia Care has four of its maximum six dispensaries in the state, according to the company website: In Portsmouth, Virginia Beach, Richmond and Short Pump.
The Virginia medical market, which launched in 2020, is projected to reach up to $25 million in sales this year and up to $95 million by 2026, according to the 2022 MJBiz Factbook.
In addition to Columbia Care and Jushi, the other licensed medical cannabis operators in Virginia include Green Leaf Medical, a Maryland-based multistate operator, and a Virginia company called Dharma Pharmaceuticals.
Recreational market launch questionable
Perhaps the biggest development in Virginia so far this year, however, is what didn’t happen – the requisite approval of two bills that would have cleared the way for the state’s recreational marijuana market.
The recreational market is projected to hit upward of $500 million in sales in 2024 if it launches as planned, according to the MJBiz Factbook, and could surpass $1 billion in sales in 2026.
The two bills – House Bill 430 and Senate Bill 391 – were shelved by Republican leaders in the House of Delegates, said JM Pedini, the executive director of Virginia NORML.
Pedini noted the Senate measure sailed through the Democrat-controlled upper chamber but didn’t move out of committee in the GOP-led House.
“There is not one single committee in the House of Delegates in which the chair of said committee would allow an adult-use retail bill to advance to the floor,” Pedini said.
As a result, Pedini doesn’t believe the recreational market will launch as planned in January 2024.
“With an originally projected date of Jan. 1, 2024, for adult-use retail sales, is that even possible given the Virginia Republican-controlled House of Delegates’ complete unwillingness to move forward with any adult-use legislation?” Pedini asked rhetorically.
“The answer to that is ‘No.’ … Unless or until House leadership decides to prioritize retail sales … there will be no path forward for adult-use retail.”
But Woloveck is more optimistic that economic and public-health issues will force the Virginia GOP and Gov. Glenn Youngkin to honor the original plan for a regulated adult-use market in 2024.
Youngkin’s office did not respond to a request for comment.
Woloveck believes the governor and the House Republicans want to take their time to ensure there aren’t any negative ramifications for public health from launching a recreational market.
He pointed to the ban on hemp-based delta-8 goods approved this past legislative session – alongside the MMJ program expansions – as part of that agenda.
Woloveck also said the Republicans are still deciding on a policy route for adult-use marijuana.
“The governor has continued to show good faith in wanting to learn … and get an adult-use program teed up and ready to go,” Woloveck said.
And, Woloveck implied, they might not have a choice.
“It makes sense that the Republicans are going to get something that would kick into effect 1/1/24, because come (that date), adult-use sales are allowed,” Woloveck said.
He added that his understanding of the legislation approved in 2021 that legalized adult-use marijuana and set the Jan. 1, 2024, start date for sales is that the launch isn’t flexible; it’s set in law.
The only question is whether Republican legislators and Youngkin will agree on a regulatory scheme to govern those sales.
“I think the Legislature and the governor are going to continue to push to make that happen, because they understand the need from a public safety perspective and a law and order perspective,” Woloveck said.
“So I feel very confident that there will be a commercial program in place on 1/1/24.”
He also noted that Youngkin made his first appointment to the state Cannabis Control Authority just this month: retired police chief John Keohane.
Columbia Care’s Abebe was more circumspect.
“I think it’s entirely possible that we see a bipartisan compromise. I also don’t think it’s necessarily a fait accompli” that recreational sales will begin on time in 2024, Abebe said.
“I would be really impressed if we’re able to get everything done in this next year and have adult-use sales start on Jan. 1, 2024, but I also think there’s a lot of work to get done to accomplish something like that.”
Either way, Abebe said, it appears that there won’t be any solid answers on the rec market question for a while yet.
“I think we’ll see more movement building through September. That said, it’s difficult no matter who’s in charge to make cannabis the No. 1 issue for everyone,” she said.
In the meantime
In the absence of a state-regulated market to serve consumer demand, Pedini said, the illicit market has begun to flourish, since adult-use possession and consumption – but not sales – were legalized last year.
Pedini added it throws a wrench into the works because many of those illegal businesses are selling cannabis goods of questionable quality, which could lead to a public health issue.
“Pop-ups are definitely a thing. They weren’t before, and they are now,” Pedini said.
“People see these things – these stores that call themselves dispensaries – and they go in and buy these completely unregulated products, and everyone knows unregulated products are a threat to consumer health.”
Business
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.
The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.
Golden Roots operates the The Cannabis Revolution Dispensary.
The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.
The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.
Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.
After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.
In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.
The company requested a hearing, which the regulator scheduled for Sept. 1.
At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.
Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.
Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.
The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:
- Regulators alleged in August that Albuquerque dispensary Sawmill Sweet Leaf sold out-of-state products and didn’t have a license for extraction.
- Paradise Exotics Distro lost its license in July after regulators alleged the company sold products made in California.
Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.
Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/
Business
Marijuana companies suing US attorney general in federal prohibition challenge
Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.
According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”
Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.
The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”
The companies want the case to go before the U.S. Supreme Court.
They hired prominent law firm Boies Schiller Flexner to represent them.
The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.
Similar challenges to the federal Controlled Substances Act (CSA) have failed.
One such challenge led to a landmark Supreme Court decision in 2005.
In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.
In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.
Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.
“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.
“Moreover, the facts on which those precedents are based are no longer true.”
Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”
While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.
“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”
Business
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.
The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).
Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.
Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.
That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.
Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.
Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.
A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.
Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/
-
Business1 year ago
Pot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business1 year ago
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business1 year ago
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business1 year ago
Washington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business1 year ago
Marijuana companies suing US attorney general in federal prohibition challenge
-
Business1 year ago
Legal Marijuana Handed A Nothing Burger From NY State
-
Business1 year ago
Can Cannabis Help Seasonal Depression
-
Blogs1 year ago
Cannabis Art Is Flourishing On Etsy